| |
|
|
|
Arcadia Biosciences Inc.  
|
|
5.08 -0.26 (-0.05%) |
10-16 16:00 |
|
Open: |
5.27 |
Pre close: |
5.34 |
Target:
|
6.40 
|
|
High: |
5.47 |
Low: |
5.04 |
Resistance:
|
5.48
6.38
|
|
Volume: |
843,356 |
Market Cap: |
44M |
Support:
|
4.02
3.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.86
 |
MACD |
MACD(12,26):
|
-0.22 |
|
MA(20): |
4.89 |
Signal(12,26,9): |
-0.31 |
|
MA(100): |
4.67 |
Stochastic Oscillator |
%K(14,3):
|
70.63 |
|
MA(250): |
4.88 |
%D(3): |
55.29 |
|
Average Volume(K) |
3-Month: |
350418
|
52-Week |
High:
|
10.40 |
|
10-Days: |
69087 |
Low: |
1.82 |
|
RSI |
RSI(14):
|
49.39 |
Change(%): |
2.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.942 |
Return on Equity (ttm) |
-55.7 |
Shares Out. (M) |
6.27 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-39.1 |
Shares Float (M) |
4.70 |
|
EPS Est. Next Year |
-0.220 |
PEG Ratio |
-0.09 |
% Held by Insiders |
33.31 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
-53.4 |
% Held by Institutions |
5.92 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
-0.841 |
Shares Short (K) |
473 |
|
Book Value (p.s.) |
1.320 |
EBITDA (p.s.) |
-2.794 |
P/E |
-5.39 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.85 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.14 |
P/S |
132714992.00 |
|
Operating Margin |
-1502.38 |
Levered Free Cash Flow
(M) |
-9.30 |
P/CF |
-2.10 |
|
|
|
|
|
|
